N/A N=30 Treatment

Usability of the CP950 Sound Processor

Hearing Loss

Bottom Line

View on ClinicalTrials.gov: NCT02727842 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2018

Primary outcome: Primary: Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire — 22; 28; 27; 28 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: CP950 Sound Processor (Device); Wireless programming pod (Device)
Age: Pediatric, Adult, Older Adult · 12+ yrs
Sex: All
Sponsor: Cochlear
Primary completion: Dec 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire	22; 28; 27; 28; 27; 29	—

Summary

Studying usability and gaining feedback of the CP950 Sound Processor in experienced cochlear implant recipients.

Eligibility Criteria

Inclusion Criteria

At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear
Subjects age 12 and older who are cognitively and developmentally able to complete all study related questionnaires as deemed by the principal investigator or delegated staff
At least 3 months experience with the CP810,CP920 or CP910 sound processor
Ability to use 2 zinc air batteries with their current program (MAP)
Willingness to participate in and to comply with all requirements of the protocol for the duration of the trial

Exclusion criteria

Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device
Additional disabilities that would prevent participation in evaluations
Implant types not currently supported by the CP950 sound processor (i.e.,N22)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02727842). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.